End stage renal disease Nutritional, Metabolic, Endocrine Renal disease
Conditions
Interventions
Modification of treatment mode, frequency, drawing and analysis of blood samples
Sponsors
Gambro Dialysatoren GmbH (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Stable patients with renal end stage disease being on hemodialysis for at least six months 2. Residual urine volume less than 200 ml per day 3. Ages betweeen 18 and 75 years 4. Body dry weight between 60 and 80 kg 5. Written consent 6. Well functioning vascular access
Exclusion criteria
Exclusion criteria: 1. Known human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) infection 2. Miscellaneous acute or chronic infections 3. Known coagulation disturbances 4. Known incompliance with respect to fluid restriction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood concentrations of small and large molecular weight uremic solutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Modelling of solute kinetics | — |
Countries
Germany
Outcome results
None listed